Registered entities
Heron Therapeutics, Inc.
Reg. No. 20171773963United States
HERON THERAPEUTICS, INC. /DE/
Reg. No. 818033United States
A.p. Pharma, Inc.
Reg. No. 942875566United States
Innovation
21 patent families (9 granted) — focus: Human necessities; filing pace slowing. Cited 2,515 times.
| Year | Filings |
|---|---|
| 2015 | 7 |
| 2016 | 6 |
| 2017 | 13 |
| 2018 | 10 |
| 2019 | 8 |
| 2020 | 11 |
| 2021 | 11 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 1 |
Social engagement
Social engagement: 16.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
11 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 27% |
| Private equity | 6 | 55% |
| Bank & private debt | 1 | 9% |
| Other / undisclosed | 1 | 9% |
Hiring activity
Hires periodically
5 roles tracked across 4 of the last 12 months
2 Jun 2026 · Institutional Business Manager · Chicago, Illinois
12 May 2026 · Territory Business Manager · Clark, Kentucky
15 Feb 2026 · Peri-Operative Clinical Educator Gulf Coast · Tampa
6 Feb 2026 · Manager, Quality Assurance - GMP Operations · Cary
29 Nov 2025 · Territory Healthcare Sales Manager – Oncology · Boston
Based on job postings tracked across public sources.
Recent activity
5 Jun 2026
Event
AHF 2026 Meeting
11 May 2026
Milestone
revenue